$39.82
0[0.00%]
At close: May 2
$39.82
0[0.00%]
PreMarket: 4:00PM EDT
Halozyme Therapeutics
(NASDAQ:HALO)Halozyme Therapeutics Stock (NASDAQ:HALO), Earnings Estimates, EPS, and Revenue
Halozyme Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$0.690
Quarterly Revenue Estimate
$199.8M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$829.3M
Analyze the earnings history of Halozyme Therapeutics using advanced sorting and filters.
No data available to display
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|
FAQ
When is Halozyme Therapeutics (NASDAQ:HALO) reporting earnings?
Halozyme Therapeutics (HALO) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on February 20, 2024 for Q4.
What were the latest earnings per share (EPS) for Halozyme Therapeutics (NASDAQ:HALO)?
The Actual EPS was $0.82, which missed the estimate of $0.83.
What were Halozyme Therapeutics’s (NASDAQ:HALO) revenues?
The Actual Revenue was $230M, which missed the estimate of $233.2M.
Browse earnings estimates, EPS, and revenue on all stocks.